ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,364Medicare Part D Prescriptions Filled, Including Refills

Rank: 95 out of 676

$647K Total Retail Price of All Prescriptions

Rank: 148 out of 676

559 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 559 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

17% of this provider’s 559 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 12,165 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
AMLODIPINE BESYLATE 613 479 1 3
OMEPRAZOLE 558 404 2 2
PRAVASTATIN SODIUM 519 402 3 11
FUROSEMIDE 505 425 4 4
POTASSIUM CHLORIDE 370 281 5 9
METFORMIN HCL 327 175 6 8
LISINOPRIL 326 210 7 5
LEVOTHYROXINE SODIUM 301 240 8 7
ATENOLOL 291 216 9 25
GABAPENTIN 289 210 10 10
HYDROCODONE-ACETAMINOPHEN 281 178 S3 11 1
SIMVASTATIN 267 193 12 6
HYDROCHLOROTHIAZIDE 263 182 13 12
MELOXICAM 252 192 14 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 252 192 14 16
GLIMEPIRIDE 224 140 16 30
METOPROLOL TARTRATE 190 137 17 22
WARFARIN SODIUM 186 160 18 18
CLOPIDOGREL 170 142 19 28
CEPHALEXIN 164 110 20 84
KLOR-CON M20 150 116 21 67
GLYBURIDE-METFORMIN HCL 149 87 R 22 76
DOXEPIN HCL 143 111 23 224
CIPROFLOXACIN HCL 142 116 24 45
AMITRIPTYLINE HCL 139 110 R 25 46
TRIAMTERENE-HCTZ 137 113 26 43
NEXIUM 133 119 27 23
PLAVIX 132 103 28 40
BENAZEPRIL HCL 131 112 29 58
TORSEMIDE 130 82 30 159
CITALOPRAM HBR 129 99 31 17
MECLIZINE HCL 126 118 32 83
ISOSORBIDE MONONITRATE ER 117 64 33 54
PAROXETINE HCL 114 71 34 65
ALLOPURINOL 112 83 35 31
DIGOXIN 110 76 36 52
DONEPEZIL HCL 107 95 37 24
NAPROXEN SODIUM 106 61 38 194
SULFAMETHOXAZOLE-TRIMETHOPRIM 103 75 39 74
ENALAPRIL MALEATE 103 74 39 65
MEGESTROL ACETATE 103 96 R 39 111
PREDNISONE 100 56 42 53
PHENYTOIN SODIUM EXTENDED 99 58 43 88
TRIAMTERENE-HYDROCHLOROTHIAZID 98 74 44 160
CILOSTAZOL 95 95 45 123
ZOLPIDEM TARTRATE 94 71 46 21
METOPROLOL SUCCINATE 93 79 47 14
LOVASTATIN 91 72 48 33
VERAPAMIL ER 91 54 48 101
OXYBUTYNIN CHLORIDE 90 75 50 149
CLONIDINE HCL 89 60 51 32
LOSARTAN POTASSIUM 87 80 52 34
TRAMADOL HCL 86 77 53 19
DOXYCYCLINE HYCLATE 86 61 53 82
HUMULIN 70-30 85 56 55 209
RANITIDINE HCL 82 65 56 27
EVISTA 82 82 56 119
CYCLOBENZAPRINE HCL 81 48 R 58 50
TAMSULOSIN HCL 81 76 58 38
LOSARTAN-HYDROCHLOROTHIAZIDE 80 66 60 51
NIFEDIPINE ER 77 53 61 100
FAMOTIDINE 76 47 62 64
SYNTHROID 74 70 63 48
ATORVASTATIN CALCIUM 73 57 64 20
LANTUS 67 26 65 55
DOXAZOSIN MESYLATE 66 47 66 116
CARVEDILOL 66 34 66 15
FLUTICASONE PROPIONATE 62 58 68 49
SERTRALINE HCL 61 61 69 26
ROPINIROLE HCL 61 45 69 85
FLUOXETINE HCL 59 24 71 70
NAMENDA 56 54 72 35
AMLODIPINE BESYLATE-BENAZEPRIL 56 35 72 44
SINGULAIR 56 46 72 80
SPIRONOLACTONE-HCTZ 55 42 75 251
FENOFIBRATE 54 48 76 90
ATENOLOL-CHLORTHALIDONE 53 46 77 142
DIOVAN HCT 52 46 78 41
LACTULOSE 52 34 78 110
PROAIR HFA 51 37 80 79
TERAZOSIN HCL 51 50 80 145
ALBUTEROL SULFATE 50 45 82 205
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.